![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Valeant Coughs Up $54 Million to Settle Kickback, Fraud Allegations
Valeant Coughs Up $54 Million to Settle Kickback, Fraud Allegations
![](https://www.fdanews.com/ext/resources/test/Device_Images3/moneyinhand.gif?t=1435858774&width=430)
Valeant will pony up at least $54 million to settle Justice Department allegations that one of its subsidiaries paid kickbacks to convince physicians to prescribe more of its products.
Under the deal, Valeant will shell out $46.53 million to the federal government and earmark another $7.47 million to resolve state claims against subsidiary Salix Pharmaceuticals.
The Justice Department is contending that the company violated the federal Anti-Kickback Statute and False Claims Act by disguising payments to physicians as speaker programs between January 2009 and December 2013. Valeant purchased the company a year and a half later.
Upcoming Events
-
21Oct